The University of Texas Health Science Center at Houston News Room The University of Texas Health Science Center at Houston UT-Houston News Room

Darkness Unveils Vital Metabolic Fuel Switch Between Sugar and Fat

 

HOUSTON – (Jan. 18, 2006) – Constant darkness throws a molecular switch in mammals that shifts the body’s fuel consumption from glucose to fat and induces a state of torpor in mice, a research team led by scientists at The University of Texas Medical School at Houston reports in the Jan. 19 edition of Nature.

While their findings could provide new insight into mammalian hibernation, researchers note that the pivotal metabolic signal that emerged from the dark presents a new target for obesity and type 2 diabetes research, as well as a new potential method for swiftly reducing body temperature. A series of experiments pinpointed 5-prime adenosine monophosphate (5’-AMP) as the key molecular mediator of the constant darkness effect, switching mice from a glucose-burning, fat-storing state to a fat-burning, glucose-conserving lethargy.

Active mammals – a bear foraging for food or a human running a marathon – undergo a similar switch, burning glucose first then switching to fat after blood sugar is consumed.

“How does the body know when to switch? 5’-AMP is the signal. I believe it’s the same metabolic system, whether we are talking about hibernation or not,” said senior author Cheng Chi Lee, Ph.D., professor of biochemistry.

The team started with a basic question: What actually sets off hibernation? “These animals dig deep burrows,” said Lee, an expert in circadian rhythms. “They are constantly in the dark. Why not darkness as a switch?”

Mice do not hibernate but they can slip into a similar short-term state of torpor. Lee and colleagues started with a microarray analysis of gene expression in the livers of mice subject to the usual light-dark cycle and those kept in the dark for 48 hours.

One gene fired up in the dark – procolipase, which produces an enzyme (CLPS) required for degrading dietary fat. Expression of the gene previously was thought to be restricted to the pancreas and gastrointestinal tract. Yet messenger RNA for CLPS (mClps) was found in the livers of mice exposed to prolonged dark, an unexpected finding.

They repeated the experiment in mice with natural, or “wild type,” genomes and three strains of mutant mice with impaired circadian rhythms. Mice exposed to regular light-dark cycles showed no sign of the gene’s expression in their livers – it remained in the pancreas and stomach. All four genotypes of mouse kept in constant darkness had mClps expressed not only in their livers but in all peripheral tissue except the brain and kidneys.

“This is the first example of a gene that is turned on by darkness, where darkness itself is a signal,” Lee said. “Twelve hours of darkness didn’t do the job; it had to be at least 48 hours.”

Findings suggested the gene’s expression was mediated by something in the blood. Tests showed elevated levels of 5’-AMP in the blood of mice exposed to constant darkness compared to those kept in the regular light-dark cycle.

To confirm the connection, the team injected 5’-AMP into mice exposed to a regular light-dark cycle. Three to four hours after injection, mClps was expressed in the livers of these mice and further tests showed expression in all tissues except the brain.

Core body temperature dropped swiftly in mice injected with 5’-AMP, leaving them in a temporary state of torpor. Mice kept in constant dark also ate less, lost weight, and showed evidence of increased fat consumption, all hallmarks of hibernation in larger mammals.

The authors note that 5’-AMP has previously been shown to regulate enzyme activity for glucose usage and production. The brain requires glucose to function. By switching the primary source of energy in other organs from glucose to fat, 5’-AMP conserves glucose for brain function, the paper notes. 

“5’-AMP is a pivotal metabolic signal whose circulatory level determines the balance of the peripheral organ energy supply between glucose, glycogen and fat,” the authors conclude. This raises the longer-term possibility of 5’-AMP based therapies for obesity or type 2 diabetes. And the molecule’s ability to rapidly drop body temperature could be a useful tool during surgery or emergency trauma care, when lower temperatures are desired.

Injecting mice with 5’-AMP’s more glamorous molecular cousins – adenosine triphosphate (ATP), adenosine diphosphate (ADP), both vital to providing energy to cells, and the signaling molecule cyclic AMP – did not produce the same effect.

Study co-authors are Michael Blackburn, Ph.D., associate professor of biochemistry and an expert in adenosine signaling; first author Jianfa Zhang, a post-doctoral fellow in biochemistry, and Krista Kaasik, now at the Institute of Molecular and Cell Biology at Tartu University in Estonia.

Media Contact: Scott Merville
Media Hotline:  713.500.3030